PRAN - Prana Biotechnology Limited

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue101.555106.223135.921
Cost of Revenue---
Gross Profit101.555106.223135.921
Operating Expenses
Research Development4,372.4657,137.2839,452.421
Selling General and Administrative1,007.847-637.317-1,164.287
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-5,278.757-6,393.744-8,152.213
Income from Continuing Operations
Total Other Income/Expenses Net-506.419638.3083,628.925
Earnings Before Interest and Taxes-5,785.176-5,755.436-4,523.288
Interest Expense---
Income Before Tax-5,785.176-5,755.436-4,523.288
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-5,785.176-5,755.436-4,523.288
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-5,785.176-5,755.436-4,523.288
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-5,785.176-5,755.436-4,523.288